Rankings
▼
Calendar
PTCT FY 2018 Earnings — PTC Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
PTCT
PTC Therapeutics, Inc.
$5B
FY 2018 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$265M
+36.2% YoY
Gross Profit
$252M
95.2% margin
Operating Income
-$116M
-43.7% margin
Net Income
-$128M
-48.4% margin
EPS (Diluted)
$-2.75
Cash Flow
Operating Cash Flow
-$28M
Free Cash Flow
-$43M
Stock-Based Comp.
$33M
Balance Sheet
Total Assets
$1.1B
Total Liabilities
$768M
Stockholders' Equity
$351M
Cash & Equivalents
$228M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$265M
$194M
+36.2%
Gross Profit
$252M
$190M
+32.8%
Operating Income
-$116M
-$64M
-79.9%
Net Income
-$128M
-$79M
-62.1%
← Q4 2017
All Quarters
Q1 2018 →